Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 07:00:56 28/07/2026 BST			5-day change	1st Jan Change
196.10 ^EUR	-1.78%		+1.76%	+14.11%

07-20	Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix…
07-13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	47.74B		AAA
REVOLUTION MEDICINES, INC.	39.98B	-	B	-	-
BEONE MEDICINES AG	36.23B		-
IQVIA HOLDINGS INC.	35.59B		AAA
CELLTRION, INC.	27.91B		A
ASCENDIS PHARMA A/S	16.71B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.45B		BBB
EUROFINS SCIENTIFIC SE	13.21B		AA
ICON PUBLIC LIMITED COMPANY	12.93B		AAA
BIO-TECHNE CORPORATION	11.16B		AA
ABIVAX	11.1B	-	BBB	-	-
APOGEE THERAPEUTICS, INC.	10.08B	-	B	-	-
PHARMARON BEIJING CO., LTD.	9.54B		AA
IONIS PHARMACEUTICALS, INC.	9.25B	-	A	-	-
KYMERA THERAPEUTICS, INC.	9.05B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	8.8B	-	B	-	-
ALKERMES PLC	8.79B		A
PROTAGONIST THERAPEUTICS, INC.	8.72B		BB		-
QIAGEN N.V.	8.5B		AAA
Average	17.99B		A
Weighted average by Cap.			A